{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T12:28:12Z","timestamp":1773145692579,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum D\u00fcsseldorf. Anstalt \u00f6ffentlichen Rechts"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Regional citrate anticoagulation (RCA) is recommended during continuous renal replacement therapy. Compared to systemic anticoagulation, RCA provides a longer filter lifespan with the risk of metabolic alkalosis and impaired calcium homeostasis. Surprisingly, most RCA protocols are designed for continuous veno-venous hemodialysis or hemodiafiltration. Effective protocols for continuous veno-venous hemofiltration (CVVH) are rare, although CVVH is a standard treatment for high-molecular-weight clearance. Therefore, we evaluated a new RCA protocol for postdilution CVVH.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is a monocentric prospective interventional study to evaluate a new RCA protocol for postdilution CVVH. We recruited surgical patients with stage III acute kidney injury who needed renal replacement therapy. We recorded dialysis and RCA data and hemodynamic and laboratory parameters during treatment sessions of 72\u00a0h. The primary endpoint was filter patency at 72\u00a0h. The major safety parameters were metabolic alkalosis and severe hypocalcemia at any time.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We included 38 patients who underwent 66 treatment sessions. The mean filter lifespan was 66\u2009\u00b1\u200912\u00a0h, and 44 of 66 (66%) filters were patent at 72\u00a0h. After censoring for non-CVVH-related cessation of treatment, 83% of all filters were patent at 72\u00a0h. The delivered dialysis dose was 28\u2009\u00b1\u20095\u00a0ml\/kgBW\/h. The serum levels of creatinine, urea and beta2-microglobulin decreased significantly from day 0 to day 3. Metabolic alkalosis occurred in one patient. An iCa<jats:sup>++<\/jats:sup> below 1.0\u00a0mmol\/L occurred in four patients. Citrate accumulation did not occur.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We describe a safe, effective, and easy-to-use RCA protocol for postdilution CVVH. This protocol provides a long and sustained filter lifespan without serious adverse effects. The risk of metabolic alkalosis and hypocalcemia is low. Using this protocol, a recommended dialysis dose can be safely administered with effective clearance of low- and middle-molecular-weight molecules.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>The study was approved by the medical ethics committee of Heinrich-Heine University Duesseldorf (No. 2018-82KFogU). The trial was registered in the local study register of the university (No: 2018044660) on 07\/04\/2018 and was retrospectively registered at ClinicalTrials.gov (ClinicalTrials.gov Identifier: NCT03969966) on 31\/05\/2019.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-024-03659-y","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T12:06:41Z","timestamp":1720526801000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A safe and effective protocol for postdilution hemofiltration with regional citrate anticoagulation"],"prefix":"10.1186","volume":"25","author":[{"given":"Thomas","family":"Dimski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timo","family":"Brandenburger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Vollmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Detlef","family":"Kindgen-Milles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,9]]},"reference":[{"issue":"8","key":"3659_CR1","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00134-015-3934-7","volume":"41","author":"EA Hoste","year":"2015","unstructured":"Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41(8):1411\u201323.","journal-title":"Intensive Care Med"},{"issue":"3","key":"3659_CR2","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1097\/CCM.0000000000004831","volume":"49","author":"R Bellomo","year":"2021","unstructured":"Bellomo R, Baldwin I, Ronco C, Kellum JA. ICU-based renal replacement therapy. Crit Care Med. 2021;49(3):406\u201318.","journal-title":"Crit Care Med"},{"issue":"1","key":"3659_CR3","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13054-016-1299-0","volume":"20","author":"C Liu","year":"2016","unstructured":"Liu C, Mao Z, Kang H, Hu J, Zhou F. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials. Crit Care. 2016;20(1):144.","journal-title":"Crit Care"},{"issue":"6","key":"3659_CR4","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1097\/CCM.0b013e3181a00a92","volume":"37","author":"S Morgera","year":"2009","unstructured":"Morgera S, Schneider M, Slowinski T, Vargas-Hein O, Zuckermann-Becker H, Peters H, et al. A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status. Crit Care Med. 2009;37(6):2018\u201324.","journal-title":"Crit Care Med"},{"issue":"4","key":"3659_CR5","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1053\/j.ajkd.2021.01.017","volume":"78","author":"H Rhee","year":"2021","unstructured":"Rhee H, Berenger B, Mehta RL, Macedo E. Regional citrate anticoagulation for continuous kidney replacement therapy with calcium-containing solutions: a cohort study. Am J Kidney Dis. 2021;78(4):550-9 e1.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"3659_CR6","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/s12882-019-1648-8","volume":"20","author":"I Lenga","year":"2019","unstructured":"Lenga I, Hopman WM, O\u2019Connell AJ, Hume F, Wei CCY. Flexitrate regional citrate anticoagulation in continuous venovenous hemodiafiltration: a retrospective analysis. BMC Nephrol. 2019;20(1):452.","journal-title":"BMC Nephrol"},{"issue":"4","key":"3659_CR7","first-page":"695","volume":"68","author":"A Koska","year":"2021","unstructured":"Koska A, Kowalik MM, Lango-Maziarz A, Karolak W, Jagielak D, Lango R. Ionic homeostasis, acid-base balance and the risk of citrate accumulation in patients after cardiovascular surgery treated with continuous veno-venous haemofiltration with post-dilution regional citrate anticoagulation - an observational case-control study. Acta Biochim Pol. 2021;68(4):695\u2013704.","journal-title":"Acta Biochim Pol"},{"issue":"1","key":"3659_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12871-021-01319-4","volume":"21","author":"Y Shi","year":"2021","unstructured":"Shi Y, Qin HY, Peng JM, Hu XY, Du B. Feasibility and efficacy of modified fixed citrate concentration protocol using only commercial preparations in critically ill patients: a prospective cohort study with a historical control group. BMC Anesthesiol. 2021;21(1):96.","journal-title":"BMC Anesthesiol"},{"issue":"1","key":"3659_CR9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/01.MAT.0000104823.48673.BD","volume":"50","author":"A Wynckel","year":"2004","unstructured":"Wynckel A, Cornillet J, Bene B, Stolz A, Lepouse C, Paris B, et al. Improved removal of small proteins using continuous venovenous hemofiltration to treat acute renal failure. ASAIO J. 2004;50(1):81\u20134.","journal-title":"ASAIO J"},{"issue":"Suppl. 1","key":"3659_CR10","first-page":"1","volume":"2","author":"KDIGO","year":"2012","unstructured":"KDIGO. KDIGO clinical practice guideline for acute kidney injury. Kidney International. 2012;2(Suppl. 1):1\u2013138.","journal-title":"Kidney International."},{"issue":"6","key":"3659_CR11","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00134-021-06401-6","volume":"47","author":"ST Vaara","year":"2021","unstructured":"Vaara ST, Ostermann M, Bitker L, Schneider A, Poli E, Hoste E, et al. Restrictive fluid management versus usual care in acute kidney injury (REVERSE-AKI): a pilot randomized controlled feasibility trial. Intensive Care Med. 2021;47(6):665\u201373.","journal-title":"Intensive Care Med"},{"issue":"16","key":"3659_CR12","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1001\/jama.2020.18618","volume":"324","author":"A Zarbock","year":"2020","unstructured":"Zarbock A, Kullmar M, Kindgen-Milles D, Wempe C, Gerss J, Brandenburger T, et al. Effect of regional citrate anticoagulation vs systemic heparin anticoagulation during continuous kidney replacement therapy on dialysis filter life span and mortality among critically Ill patients with acute kidney injury: a randomized clinical trial. JAMA. 2020;324(16):1629\u201339.","journal-title":"JAMA"},{"key":"3659_CR13","doi-asserted-by":"publisher","first-page":"7814952","DOI":"10.1155\/2022\/7814952","volume":"2022","author":"MBR Zakariah","year":"2022","unstructured":"Zakariah MBR, Ajmi Alotaibi Y, Guo Y, Tran-Trung K, Elahi MM. An analytical study of speech pathology detection based on MFCC and deep neural networks. Comput Math Methods Med. 2022;2022:7814952.","journal-title":"Comput Math Methods Med"},{"issue":"6","key":"3659_CR14","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/MCC.0000000000000547","volume":"24","author":"D Kindgen-Milles","year":"2018","unstructured":"Kindgen-Milles D, Brandenburger T, Dimski T. Regional citrate anticoagulation for continuous renal replacement therapy. Curr Opin Crit Care. 2018;24(6):450\u20134.","journal-title":"Curr Opin Crit Care"},{"issue":"3","key":"3659_CR15","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1159\/000448801","volume":"42","author":"R Jacobs","year":"2016","unstructured":"Jacobs R, Honore PM, Hendrickx I, Spapen HD. Regional citrate anticoagulation for continuous renal replacement therapy: all citrates are not created equal! Blood Purif. 2016;42(3):219\u201320.","journal-title":"Blood Purif"},{"issue":"4","key":"3659_CR16","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1159\/000452755","volume":"42","author":"CJ Kirwan","year":"2016","unstructured":"Kirwan CJ, Hutchison R, Ghabina S, Schwarze S, Beane A, Ramsay S, et al. Implementation of a simplified regional citrate anticoagulation protocol for post-dilution continuous hemofiltration using a bicarbonate buffered. Calcium containing replacement solution. Blood Purif. 2016;42(4):349\u201355.","journal-title":"Blood Purif"},{"issue":"1\u20133","key":"3659_CR17","first-page":"129","volume":"45","author":"CJ Kirwan","year":"2017","unstructured":"Kirwan CJ, Jackson L, Prowle JR. A continuous renal replacement therapy protocol on the updated nikkiso aquarius platform using regional citrate as first-line anticoagulation significantly improves filter life span but the position of the vascular access is key. Blood Purif. 2017;45(1\u20133):129\u201330.","journal-title":"Blood Purif"},{"issue":"3","key":"3659_CR18","doi-asserted-by":"publisher","first-page":"R111","DOI":"10.1186\/cc11403","volume":"16","author":"S Morabito","year":"2012","unstructured":"Morabito S, Pistolesi V, Tritapepe L, Zeppilli L, Polistena F, Strampelli E, et al. Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution. Crit Care. 2012;16(3):R111.","journal-title":"Crit Care"},{"key":"3659_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13054-015-0822-z","volume":"19","author":"F Stucker","year":"2015","unstructured":"Stucker F, Ponte B, Tataw J, Martin PY, Wozniak H, Pugin J, et al. Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial. Crit Care. 2015;19:91.","journal-title":"Crit Care"},{"issue":"26","key":"3659_CR20","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1056\/NEJMct1206045","volume":"367","author":"A Tolwani","year":"2012","unstructured":"Tolwani A. Continuous renal-replacement therapy for acute kidney injury. N Engl J Med. 2012;367(26):2505\u201314.","journal-title":"N Engl J Med"},{"issue":"11","key":"3659_CR21","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.2215\/CJN.02410220","volume":"15","author":"P Hatamizadeh","year":"2020","unstructured":"Hatamizadeh P, Tolwani A, Palevsky P. Revisiting filtration fraction as an index of the risk of hemofilter clotting in continuous venovenous hemofiltration. Clin J Am Soc Nephrol. 2020;15(11):1660\u20132.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"3659_CR22","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1093\/ckj\/sfac167","volume":"15","author":"F Maduell","year":"2022","unstructured":"Maduell F, Broseta JJ, Rodr\u00edguez-Espinosa D, Del Risco J, Rodas LM, Arias-Guill\u00e9n M, et al. Comparison of four medium cut-off dialyzers. Clin Kidney J. 2022;15(12):2292\u20139.","journal-title":"Clin Kidney J"},{"issue":"suppl_3","key":"3659_CR23","doi-asserted-by":"publisher","first-page":"iii12","DOI":"10.1093\/ndt\/gfy224","volume":"33","author":"I Masakane","year":"2018","unstructured":"Masakane I, Sakurai K. Current approaches to middle molecule removal: room for innovation. Nephrol Dial Transplant. 2018;33(suppl_3):iii12\u201321.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"3659_CR24","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/1744-9987.12656","volume":"22","author":"M Siebeck","year":"2018","unstructured":"Siebeck M, Dimski T, Brandenburger T, Slowinski T, Kindgen-Milles D. Super high-flux continuous venovenous hemodialysis using regional citrate anticoagulation: long-term stability of middle molecule clearance. Ther Apher Dial. 2018;22(4):355\u201364.","journal-title":"Ther Apher Dial"},{"issue":"4","key":"3659_CR25","doi-asserted-by":"publisher","first-page":"e0215823","DOI":"10.1371\/journal.pone.0215823","volume":"14","author":"L Weidhase","year":"2019","unstructured":"Weidhase L, Haussig E, Haussig S, Kaiser T, de Fallois J, Petros S. Middle molecule clearance with high cut-off dialyzer versus high-flux dialyzer using continuous veno-venous hemodialysis with regional citrate anticoagulation: a prospective randomized controlled trial. PLoS ONE. 2019;14(4):e0215823.","journal-title":"PLoS ONE"},{"issue":"4","key":"3659_CR26","doi-asserted-by":"publisher","first-page":"R146","DOI":"10.1186\/cc11458","volume":"16","author":"JO Friedrich","year":"2012","unstructured":"Friedrich JO, Wald R, Bagshaw SM, Burns KE, Adhikari NK. Hemofiltration compared to hemodialysis for acute kidney injury: systematic review and meta-analysis. Crit Care. 2012;16(4):R146.","journal-title":"Crit Care"},{"issue":"1","key":"3659_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/ncpneph1002","volume":"5","author":"RA Ward","year":"2009","unstructured":"Ward RA. Does increased removal of high-molecular-weight toxins improve the survival of hemodialysis patients? Nat Clin Pract Nephrol. 2009;5(1):14\u20135.","journal-title":"Nat Clin Pract Nephrol"},{"issue":"3","key":"3659_CR28","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1053\/j.ajkd.2008.05.011","volume":"52","author":"A Santoro","year":"2008","unstructured":"Santoro A, Mancini E, Bolzani R, Boggi R, Cagnoli L, Francioso A, et al. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial. Am J Kidney Dis. 2008;52(3):507\u201318.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"3659_CR29","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1093\/ckj\/sfv040","volume":"8","author":"IM Mostovaya","year":"2015","unstructured":"Mostovaya IM, Grooteman MP, Basile C, Davenport A, de Roij van Zuijdewijn CL, Wanner C, et al. High convection volume in online post-dilution haemodiafiltration: relevance, safety and costs. Clin Kidney J. 2015;8(4):368\u201373.","journal-title":"Clin Kidney J"},{"issue":"8","key":"3659_CR30","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1056\/NEJMoa2304820","volume":"389","author":"PJ Blankestijn","year":"2023","unstructured":"Blankestijn PJ, Vernooij RWM, Hockham C, Strippoli GFM, Canaud B, Hegbrant J, et al. Effect of hemodiafiltration or hemodialysis on mortality in kidney failure. N Engl J Med. 2023;389(8):700\u20139.","journal-title":"N Engl J Med"},{"issue":"1","key":"3659_CR31","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1038\/s41598-022-05867-8","volume":"12","author":"P Thanapongsatorn","year":"2022","unstructured":"Thanapongsatorn P, Chaijamorn W, Sirivongrangson P, Tachaboon S, Peerapornratana S, Lumlertgul N, et al. Citrate pharmacokinetics in critically ill liver failure patients receiving CRRT. Sci Rep. 2022;12(1):1815.","journal-title":"Sci Rep"},{"key":"3659_CR32","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/s13054-015-1066-7","volume":"19","author":"T Slowinski","year":"2015","unstructured":"Slowinski T, Morgera S, Joannidis M, Henneberg T, Stocker R, Helset E, et al. Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study. Crit Care. 2015;19:349.","journal-title":"Crit Care"},{"issue":"1","key":"3659_CR33","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12882-021-02443-6","volume":"22","author":"L Yessayan","year":"2021","unstructured":"Yessayan L, Sohaney R, Puri V, Wagner B, Riddle A, Dickinson S, et al. Regional citrate anticoagulation \u201cnon-shock\u201d protocol with pre-calculated flow settings for patients with at least 6 L\/hour liver citrate clearance. BMC Nephrol. 2021;22(1):244.","journal-title":"BMC Nephrol"},{"issue":"1","key":"3659_CR34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s40620-020-00799-w","volume":"34","author":"G Donati","year":"2021","unstructured":"Donati G, Angeletti A, Gasperoni L, Piscaglia F, Croci Chiocchini AL, Scrivo A, et al. Detoxification of bilirubin and bile acids with intermittent coupled plasmafiltration and adsorption in liver failure (HERCOLE study). J Nephrol. 2021;34(1):77\u201388.","journal-title":"J Nephrol"},{"issue":"4","key":"3659_CR35","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s40620-020-00864-4","volume":"34","author":"F Di Mario","year":"2021","unstructured":"Di Mario F, Regolisti G, Greco P, Maccari C, Superchi E, Morabito S, et al. Prevention of hypomagnesemia in critically ill patients with acute kidney injury on continuous kidney replacement therapy: the role of early supplementation and close monitoring. J Nephrol. 2021;34(4):1271\u20139.","journal-title":"J Nephrol"},{"issue":"1\u20133","key":"3659_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000440972","volume":"41","author":"M Zakharchenko","year":"2016","unstructured":"Zakharchenko M, Leden P, Rulisek J, Los F, Brodska H, Balik M. Ionized magnesium and regional citrate anticoagulation for continuous renal replacement therapy. Blood Purif. 2016;41(1\u20133):41\u20137.","journal-title":"Blood Purif"},{"issue":"5","key":"3659_CR37","doi-asserted-by":"publisher","first-page":"R205","DOI":"10.1186\/cc12900","volume":"17","author":"Y Yang","year":"2013","unstructured":"Yang Y, Zhang P, Cui Y, Lang X, Yuan J, Jiang H, et al. Hypophosphatemia during continuous veno-venous hemofiltration is associated with mortality in critically ill patients with acute kidney injury. Crit Care. 2013;17(5):R205.","journal-title":"Crit Care"},{"issue":"11","key":"3659_CR38","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.1093\/ndt\/gfr075","volume":"26","author":"S Demirjian","year":"2011","unstructured":"Demirjian S, Teo BW, Guzman JA, Heyka RJ, Paganini EP, Fissell WH, et al. Hypophosphatemia during continuous hemodialysis is associated with prolonged respiratory failure in patients with acute kidney injury. Nephrol Dial Transplant. 2011;26(11):3508\u201314.","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"3659_CR39","doi-asserted-by":"publisher","first-page":"e941","DOI":"10.1097\/CCM.0000000000002501","volume":"45","author":"D Khadzhynov","year":"2017","unstructured":"Khadzhynov D, Dahlinger A, Schelter C, Peters H, Kindgen-Milles D, Budde K, et al. Hyperlactatemia, lactate kinetics and prediction of citrate accumulation in critically ill patients undergoing continuous renal replacement therapy with regional citrate anticoagulation. Crit Care Med. 2017;45(9):e941\u20136.","journal-title":"Crit Care Med"},{"issue":"2","key":"3659_CR40","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jcrc.2013.10.015","volume":"29","author":"D Khadzhynov","year":"2014","unstructured":"Khadzhynov D, Schelter C, Lieker I, Mika A, Staeck O, Neumayer HH, et al. Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation. J Crit Care. 2014;29(2):265\u201371.","journal-title":"J Crit Care"},{"issue":"2","key":"3659_CR41","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1744-9987.2012.01101.x","volume":"17","author":"R Kalb","year":"2013","unstructured":"Kalb R, Kram R, Morgera S, Slowinski T, Kindgen-Milles D. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk. Ther Apher Dial. 2013;17(2):202\u201312.","journal-title":"Ther Apher Dial"},{"issue":"1","key":"3659_CR42","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13613-021-00850-4","volume":"11","author":"P Koglberger","year":"2021","unstructured":"Koglberger P, Klein SJ, Lehner GF, Bellmann R, Peer A, Schwarzler D, et al. Low bicarbonate replacement fluid normalizes metabolic alkalosis during continuous veno-venous hemofiltration with regional citrate anticoagulation. Ann Intensive Care. 2021;11(1):62.","journal-title":"Ann Intensive Care"},{"issue":"1","key":"3659_CR43","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s13054-017-1870-3","volume":"21","author":"M Klingele","year":"2017","unstructured":"Klingele M, Stadler T, Fliser D, Speer T, Groesdonk HV, Raddatz A. Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction. Crit Care. 2017;21(1):294.","journal-title":"Crit Care"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03659-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-024-03659-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03659-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T12:09:20Z","timestamp":1720526960000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-024-03659-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,9]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3659"],"URL":"https:\/\/doi.org\/10.1186\/s12882-024-03659-y","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,9]]},"assertion":[{"value":"16 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the medical ethics committee of Heinrich-Heine University Duesseldorf (No. 2018-82KFogU).The study was conducted in accordance with the Declaration of Helsinki. Informed consent was obtained from included patients prior to study inclusion.The authors confirm that all ongoing and related trials for this intervention are registered.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"D.K. has received lecture honoraria from Diamed Medizintechnik, Germany.T.D., T.B. and C.V have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"218"}}